Lymphoma, FollicularLymphomaDisease-Free SurvivalLymphoma, B-CellLymphoma, Non-HodgkinPrognosisSurvival RateNeoplasm StagingTreatment OutcomeLymphoma, Large B-Cell, DiffuseSurvival AnalysisChromosomes, Human, Pair 18Retrospective StudiesCombined Modality TherapyChromosomes, Human, Pair 14Lymphoma, T-CellNeoplasm Recurrence, LocalAntineoplastic Combined Chemotherapy ProtocolsKaplan-Meier EstimateFollow-Up StudiesAntibodies, Monoclonal, Murine-DerivedBreast NeoplasmsTumor Markers, BiologicalImmunohistochemistryCyclophosphamideTranslocation, GeneticBurkitt LymphomaLymphoma, B-Cell, Marginal ZoneVincristineChemotherapy, AdjuvantLymphoma, Mantle-CellRadiotherapy, AdjuvantLymphatic MetastasisProportional Hazards ModelsCell SurvivalRecurrencePrednisoneGenes, bcl-2Time FactorsRadiotherapy DosageHodgkin DiseaseProto-Oncogene Proteins c-bcl-6DoxorubicinGene RearrangementAntineoplastic AgentsAntigens, CD20Immunoenzyme TechniquesLymph NodesFluorouracilRemission InductionGene Expression Regulation, NeoplasticMultivariate AnalysisAntibodies, MonoclonalNeoplasm InvasivenessCarcinoma, Squamous CellImmunoglobulin Heavy ChainsProspective StudiesColorectal NeoplasmsProto-Oncogene Proteins c-bcl-2Predictive Value of TestsCarcinoma, Ductal, BreastPseudolymphomaLymphoma, T-Cell, CutaneousCarcinomaLiver NeoplasmsTransplantation, AutologousNeoplasm GradingAdenocarcinomaNeprilysinLymphoma, AIDS-RelatedLymphoma, T-Cell, PeripheralReceptors, EstrogenRisk FactorsGerminal CenterLymphoma, Large-Cell, AnaplasticSurvivalReceptor, erbB-2ImmunophenotypingB-LymphocytesDisease ProgressionSalvage TherapyGenes, ImmunoglobulinRadioimmunotherapyEtoposideLymphoma, Large-Cell, ImmunoblasticIn Situ Hybridization, FluorescenceLeukemia, Lymphocytic, Chronic, B-CellPolymerase Chain ReactionNeoplasm ProteinsDNA, NeoplasmHematopoietic Stem Cell TransplantationNeoplasm MetastasisCisplatinGenes, Immunoglobulin Heavy ChainGene Rearrangement, B-Lymphocyte, Heavy ChainDrug Administration ScheduleLung NeoplasmsNeoplasm, ResidualTeniposideGraft Survival